[Melanoma, from diagnosis to treatment]

Barouyr Baroudjian; Cécile Pagès; Céleste Lebbé

doi:10.1016/j.revinf.2015.12.022

[Melanoma, from diagnosis to treatment]

Rev Infirm. 2016 Mar:(219):16-8. doi: 10.1016/j.revinf.2015.12.022.

[Article in French]

Authors

Barouyr Baroudjian¹, Cécile Pagès², Céleste Lebbé²

Affiliations

¹ Unité d'oncodermatologie, service de dermatologie du Professeur Bagot, Hôpital Saint-Louis, 1 avenue Claude-Vellefaux, 75010, Paris, France. Electronic address: [email protected].
² Unité d'oncodermatologie, service de dermatologie du Professeur Bagot, Hôpital Saint-Louis, 1 avenue Claude-Vellefaux, 75010, Paris, France.

PMID: 26944639
DOI: 10.1016/j.revinf.2015.12.022

Abstract

Skin cancers represent a major public health problem. Cutaneous melanoma, the incidence of which is constantly increasing, has the particularity of metastasising when it is detected too late. Its treatment at the metastatic stage has evolved significantly over recent years with the arrival of targeted therapies and immunotherapies which can increase patients' survival.

Keywords: cancer; diagnosis; diagnostic; melanoma; metastasis; mélanome; métastase; prise en charge; treatment.

Publication types

English Abstract
Review

MeSH terms

Humans
Melanoma / diagnosis*
Melanoma / epidemiology
Melanoma / pathology
Melanoma / therapy*
Molecular Targeted Therapy / trends
Neoplasm Staging
Risk Factors
Skin Neoplasms / diagnosis*
Skin Neoplasms / epidemiology
Skin Neoplasms / pathology
Skin Neoplasms / therapy*